Sentence examples for endogenous competitive from inspiring English sources

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and contributes to endothelial dysfunction.

ADMA, an endogenous competitive inhibitor of NO synthase, is known to impair NO bioavailability and endothelial function [ 4- 7].

Loss of the endogenous competitive protein can also be crucial for visualising weak protein interactions by BiFC.

Other conditions that can uncouple eNOS include relative deficiency of its substrate, arginine and the presence of an endogenous competitive NOS inhibitor, asymmetric dimethyl- L-arginine (ADMA) [ 11].

Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of NOS, and serum ADMA levels have been suggested to be a surrogate marker of endothelial dysfunction and/or angiosclerosis.

Several mechanisms exist for negatively regulating IL-1RI signalling, including IL-1RII that binds both IL-1α and IL-1β and acts as a decoy receptor, and IL-1Ra that serves as an endogenous competitive inhibitor of IL-1α and IL-1β by binding but not activating IL-1RI (Dinarello, 2009).

Each real-time NASBA diagnostics assay includes an endogenous non-competitive Internal Amplification Control (IAC) to amplify the splice variant 1 mRNA of the Homo sapiens TBP gene from human total RNA.

N-arachidonyl-glycine, N-arachidonyl-γ-aminobutyric acid and N-arachidonyl-D-alanine have been described as endogenous non-competitive inhibitors of GlyT2a, but not GlyT1b 175, 175, 204.

It is an endogenous non-competitive antagonist of nicotine-evoked catecholamine secretion (O'Connor and Deftos 1986; O'Connor et al. 2002; Mahata et al. 1997, 2000, 2004; Herrero et al. 2002; Mahapatra et al. 2005; Mahata et al. 2010), which induces vasodilatation through both inhibition of catecholamine release and increased circulating levels of histamine (Kennedy et al. 1998).

The issue is further complicated by the understanding that miRNA are involved in more complex regulatory pathways in competition with other competitive endogenous RNAs (ceRNA) including pseudogenes and long non-coding RNAs (lncRNAs; Salmena et al, 2011).

Here, considering recent research progress in microRNAs (miRNAs) and competitive endogenous RNAs (ceRNAs), we speculate that viral RNAs act as sponges and can sequester endogenous miRNAs within infected cells, thus cross-regulating the stability and translational efficiency of host mRNAs with shared miRNA response elements.